Conditions: Hepatitis B, Chronic
Keywords: Chronic Hepatitis B Virus, Liver Transplant
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 109
Healthy volunteers: no

Brief summary:
The purpose of this clinical research study is to learn if the study drug entecavir will prevent the recurrence of hepatitis B virus (HBV) in participants who receive an orthotopic liver transplant (OLT) due to HBV infection.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: entecavir
Intervention descriptions: intervention 1: Tablets, Oral, 1 mg, once daily, up to 72 weeks

Protocol document: